Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03959553
Recruitment Status : Not yet recruiting
First Posted : May 22, 2019
Last Update Posted : May 28, 2019
Sponsor:
Information provided by (Responsible Party):
GemVax & Kael

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : August 31, 2021
Estimated Study Completion Date : February 28, 2022